These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8276195)

  • 1. An assay for micrometastatic hepatocellular carcinoma.
    Carr BI
    Gastroenterology; 1994 Jan; 106(1):264-7. PubMed ID: 8276195
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative TNM-classification is a better prognostic indicator for recurrence of hepatocellular carcinoma after liver transplantation than albumin mRNA in peripheral blood. Liver Transplant Oncology Group.
    Peck-Radosavljevic M; Pidlich J; Bergmann M; Ferenci P; Seelos C; Wichlas M; Lipinski E; Gnant M; Gangl A; Mühlbacher F
    J Hepatol; 1998 Mar; 28(3):497-503. PubMed ID: 9551689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma.
    Hillaire S; Barbu V; Boucher E; Moukhtar M; Poupon R
    Gastroenterology; 1994 Jan; 106(1):239-42. PubMed ID: 8276187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma.
    Gion T; Taketomi A; Shimada M; Shirabe K; Hasegawa H; Takenaka K; Sugimachi K
    Hepatology; 1998 Dec; 28(6):1663-8. PubMed ID: 9828232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating albumin-mRNA by RT-PCR does not indicate metastasizing hepatocellular carcinoma.
    Leonhardt U; Ritzel U; Ottleben M; Vignoli A; Ramadori G
    Langenbecks Arch Chir; 1997; 382(2):83-6. PubMed ID: 9128873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bad streak.
    Sweetser S; Razumilava N; Kamath PS
    Gastroenterology; 2012 Mar; 142(3):432-3, 677. PubMed ID: 22285360
    [No Abstract]   [Full Text] [Related]  

  • 7. EUS-FNA of a portal vein thrombosis in a patient with a hidden hepatocellular carcinoma: confirmation technique after contrast-enhanced ultrasound.
    Moreno M; Gimeno-García AZ; Corriente MM; Nicolás-Pérez D; Brito-García A; García-Castro C; Quintero E
    Endoscopy; 2014; 46 Suppl 1 UCTN():E590-1. PubMed ID: 25502254
    [No Abstract]   [Full Text] [Related]  

  • 8. The effectiveness of selective internal radiation therapy in challenging cases of liver-predominant unresectable hepatocellular carcinoma.
    Malfertheiner P; Verslype C; Kolligs FT; Schütte K; Vandecaveye V; Paprottka PM; Ricke J
    Future Oncol; 2014 Nov; 10(15 Suppl):17-27. PubMed ID: 25478762
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravenous metastasis of primary hepatocarcinoma].
    Cheng ZY; Liu XW; Lu FG
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):311-2. PubMed ID: 14653103
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular invasion by hepatocellular carcinoma.
    Choi BI
    Abdom Imaging; 1995; 20(3):277-8. PubMed ID: 7620428
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of detecting circulating hepatocellular carcinoma cells in peripheral blood of hepatocellular carcinoma patients by nested reverse transcription-polymerase chain reaction and its clinical value: a retrospective study.
    Liu Y; Wang YR; Wang L; Song RM; Zhou B; Song ZS
    Tumori; 2014; 100(5):536-40. PubMed ID: 25343549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should hepatic resection be recommended to patients with hepatocellular carcinoma and portal vein invasion?
    Wang HL; Cucchetti A; Zhong JH; Ye XP; Gu JH; Ma L; Peng NF; Li LQ
    J Hepatol; 2016 Nov; 65(5):1057-1058. PubMed ID: 27475616
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating albumin messenger RNA in hepatocellular carcinoma: results of a multicenter prospective study.
    Barbu V; Bonnand AM; Hillaire S; Coste T; Chazouilleres O; Gugenheim J; Boucher E; Poupon R; Poupon RE
    Hepatology; 1997 Nov; 26(5):1171-5. PubMed ID: 9362358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated Portal Venous Hepatocellular Carcinoma.
    Mutai J; Nebayosi T; Sande J; Shah MV
    J Gastrointest Cancer; 2017 Mar; 48(1):80-82. PubMed ID: 26820465
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiological diagnosis and staging of hepatocellular carcinoma.
    Koito K; Suga T; Murashima Y
    Endoscopy; 1993 Jan; 25(1):131-7. PubMed ID: 8384101
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood.
    Komeda T; Fukuda Y; Sando T; Kita R; Furukawa M; Nishida N; Amenomori M; Nakao K
    Cancer; 1995 May; 75(9):2214-9. PubMed ID: 7536120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion: a helpful palliative approach.
    Schumacher G; Gebauer B
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1317-9. PubMed ID: 19702898
    [No Abstract]   [Full Text] [Related]  

  • 18. [Portal vein involvement by hepatocellular carcinoma: diagnosis with three-dimensional contrast-enhanced MR angiography].
    Lin J; Zhou KR; Wang JH; Yan ZP
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):308-12. PubMed ID: 15854505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of specificity of albumin-mRNA-positive cells as a marker of circulating hepatoma cells.
    Müller C; Petermann D; Pfeffel F; Oesterreicher C; Függer R
    Hepatology; 1997 Apr; 25(4):896-9. PubMed ID: 9096594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.